Clinical trials
Terminated Graft vs Host Disease trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
95 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2003 | 4 |
| 2004 | 2 |
| 2005 | 2 |
| 2006 | 7 |
| 2007 | 7 |
| 2008 | 8 |
| 2009 | 4 |
| 2010 | 2 |
| 2011 | 6 |
| 2012 | 3 |
| 2013 | 3 |
| 2014 | 9 |
| 2015 | 2 |
| 2016 | 4 |
| 2017 | 6 |
| 2018 | 5 |
| 2019 | 3 |
| 2020 | 4 |
| 2021 | 2 |
| 2022 | 4 |
| 2023 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 95 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| M.D. Anderson Cancer Center | 7 |
| Vanderbilt-Ingram Cancer Center | 4 |
| Fred Hutchinson Cancer Center | 3 |
| H. Lee Moffitt Cancer Center and Research Institute | 3 |
| Masonic Cancer Center, University of Minnesota | 3 |
| National Heart, Lung, and Blood Institute (NHLBI) | 3 |
| Baxalta now part of Shire | 2 |
| Dana-Farber Cancer Institute | 2 |
| Hadassah Medical Organization | 2 |
| Incyte Corporation | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Graft vs Host Disease | 95 |
| Myelodysplastic Syndromes | 23 |
| Leukemia | 22 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 21 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 18 |
| Lymphoma | 18 |
| Multiple Myeloma | 18 |
| Leukemia, Myeloid, Acute | 16 |
| Leukemia, Myeloid, Accelerated Phase | 15 |
| Lymphoma, Mantle-Cell | 15 |
Trials
Showing 1 to 25 of 95. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.